In vitro SUMOylation assay to study SUMO E3 ligase activity

Wan Shan Yang, Mel Campbell, Hsing Jien Kung, Pei Ching Chang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Small ubiquitin-like modifier (SUMO) modification is an important post-translational modification (PTM) that mediates signal transduction primarily through modulating protein-protein interactions. Similar to ubiquitin modification, SUMOylation is directed by a sequential enzyme cascade including E1-activating enzyme (SAE1/SAE2), E2-conjugation enzyme (Ubc9), and E3-ligase (i.e., PIAS family, RanBP2, and Pc2). However, different from ubiquitination, an E3 ligase is non-essential for the reaction but does provide precision and efficacy for SUMO conjugation. Proteins modified by SUMOylation can be identified by in vivo assay via immunoprecipitation with substrate-specific antibodies and immunoblotting with SUMO-specific antibodies. However, the demonstration of protein SUMO E3 ligase activity requires in vitro reconstitution of SUMOylation assays using purified enzymes, substrate, and SUMO proteins. Since in the in vitro reactions, usually SAE1/SAE2 and Ubc9, alone are sufficient for SUMO conjugation, enhancement of SUMOylation by a putative E3 ligase is not always easy to detect. Here, we describe a modified in vitro SUMOylation protocol that consistently identifies SUMO modification using an in vitro reconstituted system. A step-by-step protocol to purify catalytically active K-bZIP, a viral SUMO-2/3 E3 ligase, is also presented. The SUMOylation activities of the purified K-bZIP are shown on p53, a well-known target of SUMO. This protocol can not only be employed for elucidating novel SUMO E3 ligases, but also for revealing their SUMO paralog specificity.

Original languageEnglish
Article numbere56629
JournalJournal of Visualized Experiments
Volume2018
Issue number131
DOIs
Publication statusPublished - Jan 29 2018

Fingerprint

Sumoylation
Ubiquitin-Protein Ligases
Ubiquitin
Assays
Proteins
Enzymes
Antibodies
Ubiquitins
Signal transduction
Substrates
Demonstrations
In Vitro Techniques
Ubiquitination
Post Translational Protein Processing
Immunoprecipitation
Immunoblotting
Signal Transduction

Keywords

  • In vitro SUMOylation
  • Issue 131
  • K-bZIP
  • Molecular Biology
  • P53
  • Post-translational modification
  • SUMO E3 ligase
  • Ubc9

ASJC Scopus subject areas

  • Neuroscience(all)
  • Chemical Engineering(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

In vitro SUMOylation assay to study SUMO E3 ligase activity. / Yang, Wan Shan; Campbell, Mel; Kung, Hsing Jien; Chang, Pei Ching.

In: Journal of Visualized Experiments, Vol. 2018, No. 131, e56629, 29.01.2018.

Research output: Contribution to journalArticle

Yang, Wan Shan ; Campbell, Mel ; Kung, Hsing Jien ; Chang, Pei Ching. / In vitro SUMOylation assay to study SUMO E3 ligase activity. In: Journal of Visualized Experiments. 2018 ; Vol. 2018, No. 131.
@article{1a7b10a67ad6423d8e9f77294a21ffc5,
title = "In vitro SUMOylation assay to study SUMO E3 ligase activity",
abstract = "Small ubiquitin-like modifier (SUMO) modification is an important post-translational modification (PTM) that mediates signal transduction primarily through modulating protein-protein interactions. Similar to ubiquitin modification, SUMOylation is directed by a sequential enzyme cascade including E1-activating enzyme (SAE1/SAE2), E2-conjugation enzyme (Ubc9), and E3-ligase (i.e., PIAS family, RanBP2, and Pc2). However, different from ubiquitination, an E3 ligase is non-essential for the reaction but does provide precision and efficacy for SUMO conjugation. Proteins modified by SUMOylation can be identified by in vivo assay via immunoprecipitation with substrate-specific antibodies and immunoblotting with SUMO-specific antibodies. However, the demonstration of protein SUMO E3 ligase activity requires in vitro reconstitution of SUMOylation assays using purified enzymes, substrate, and SUMO proteins. Since in the in vitro reactions, usually SAE1/SAE2 and Ubc9, alone are sufficient for SUMO conjugation, enhancement of SUMOylation by a putative E3 ligase is not always easy to detect. Here, we describe a modified in vitro SUMOylation protocol that consistently identifies SUMO modification using an in vitro reconstituted system. A step-by-step protocol to purify catalytically active K-bZIP, a viral SUMO-2/3 E3 ligase, is also presented. The SUMOylation activities of the purified K-bZIP are shown on p53, a well-known target of SUMO. This protocol can not only be employed for elucidating novel SUMO E3 ligases, but also for revealing their SUMO paralog specificity.",
keywords = "In vitro SUMOylation, Issue 131, K-bZIP, Molecular Biology, P53, Post-translational modification, SUMO E3 ligase, Ubc9",
author = "Yang, {Wan Shan} and Mel Campbell and Kung, {Hsing Jien} and Chang, {Pei Ching}",
year = "2018",
month = "1",
day = "29",
doi = "10.3791/56629",
language = "English",
volume = "2018",
journal = "Journal of Visualized Experiments",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "131",

}

TY - JOUR

T1 - In vitro SUMOylation assay to study SUMO E3 ligase activity

AU - Yang, Wan Shan

AU - Campbell, Mel

AU - Kung, Hsing Jien

AU - Chang, Pei Ching

PY - 2018/1/29

Y1 - 2018/1/29

N2 - Small ubiquitin-like modifier (SUMO) modification is an important post-translational modification (PTM) that mediates signal transduction primarily through modulating protein-protein interactions. Similar to ubiquitin modification, SUMOylation is directed by a sequential enzyme cascade including E1-activating enzyme (SAE1/SAE2), E2-conjugation enzyme (Ubc9), and E3-ligase (i.e., PIAS family, RanBP2, and Pc2). However, different from ubiquitination, an E3 ligase is non-essential for the reaction but does provide precision and efficacy for SUMO conjugation. Proteins modified by SUMOylation can be identified by in vivo assay via immunoprecipitation with substrate-specific antibodies and immunoblotting with SUMO-specific antibodies. However, the demonstration of protein SUMO E3 ligase activity requires in vitro reconstitution of SUMOylation assays using purified enzymes, substrate, and SUMO proteins. Since in the in vitro reactions, usually SAE1/SAE2 and Ubc9, alone are sufficient for SUMO conjugation, enhancement of SUMOylation by a putative E3 ligase is not always easy to detect. Here, we describe a modified in vitro SUMOylation protocol that consistently identifies SUMO modification using an in vitro reconstituted system. A step-by-step protocol to purify catalytically active K-bZIP, a viral SUMO-2/3 E3 ligase, is also presented. The SUMOylation activities of the purified K-bZIP are shown on p53, a well-known target of SUMO. This protocol can not only be employed for elucidating novel SUMO E3 ligases, but also for revealing their SUMO paralog specificity.

AB - Small ubiquitin-like modifier (SUMO) modification is an important post-translational modification (PTM) that mediates signal transduction primarily through modulating protein-protein interactions. Similar to ubiquitin modification, SUMOylation is directed by a sequential enzyme cascade including E1-activating enzyme (SAE1/SAE2), E2-conjugation enzyme (Ubc9), and E3-ligase (i.e., PIAS family, RanBP2, and Pc2). However, different from ubiquitination, an E3 ligase is non-essential for the reaction but does provide precision and efficacy for SUMO conjugation. Proteins modified by SUMOylation can be identified by in vivo assay via immunoprecipitation with substrate-specific antibodies and immunoblotting with SUMO-specific antibodies. However, the demonstration of protein SUMO E3 ligase activity requires in vitro reconstitution of SUMOylation assays using purified enzymes, substrate, and SUMO proteins. Since in the in vitro reactions, usually SAE1/SAE2 and Ubc9, alone are sufficient for SUMO conjugation, enhancement of SUMOylation by a putative E3 ligase is not always easy to detect. Here, we describe a modified in vitro SUMOylation protocol that consistently identifies SUMO modification using an in vitro reconstituted system. A step-by-step protocol to purify catalytically active K-bZIP, a viral SUMO-2/3 E3 ligase, is also presented. The SUMOylation activities of the purified K-bZIP are shown on p53, a well-known target of SUMO. This protocol can not only be employed for elucidating novel SUMO E3 ligases, but also for revealing their SUMO paralog specificity.

KW - In vitro SUMOylation

KW - Issue 131

KW - K-bZIP

KW - Molecular Biology

KW - P53

KW - Post-translational modification

KW - SUMO E3 ligase

KW - Ubc9

UR - http://www.scopus.com/inward/record.url?scp=85042016527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042016527&partnerID=8YFLogxK

U2 - 10.3791/56629

DO - 10.3791/56629

M3 - Article

VL - 2018

JO - Journal of Visualized Experiments

JF - Journal of Visualized Experiments

SN - 1940-087X

IS - 131

M1 - e56629

ER -